(SLE)
URABRELIMAB(INNC)
IMMUNOGLOBULIN G4-KAPPA, ANTI-[HOMO SAPIENS CD47 (INTEGRIN ASSOCIATED PROTEIN, IAP, MER6, OA3)], HOMO SAPIENS MONOCLONAL ANTIBODY; GAMMA4 HEAVY CHAIN HOMO SAPIENS (1-452) [VH (HOMO SAPIENS IGHV4-4*02 (94.9%) -(IGHD) -IGHJ6*01 (94.7%)) CDR-IMGT [9.7.18] (26-34.52-58.97-114) (1-125)-HOMO SAPIENS IGHG4*01 (CH1 (126-223), HINGE 1-12 (224-235), CH2 (236-345), CH3 (346-450), CHS (451-452)) (126-452)], (139-212')-DISULFIDE WITH KAPPA LIGHT CHAIN HOMO SAPIENS (1'- 212') [V-KAPPA (HOMO SAPIENS IGKV3-11*01 (94.7%) - IGKJ4*01 (91.7%)) CDR-IMGT [6.3.8] (27-32.50-52.89-96) (1'-106') -HOMO SAPIENS IGKC*01 (100%), KM3 A45.1 (151), V101 (189) (107'-212')]; DIMER (231-231":234-234")-BISDISULFIDE, PRODUCED IN CHINESE HAMSTER OVARY (CHO) CELLS, GLYCOFORM ALFA(WHO)
URABRELIMABUM(INN)